Cadence Neuroscience Stock

Cadence Neuroscience is an early-stage company developing medical device therapies for epilepsy.

Sign up today and learn more about Cadence Neuroscience Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Cadence Neuroscience Stock

Cadence Neuroscience is an early-stage company developing new medical device therapies for the treatment of epilepsy, central pain, and other neurological disorders. The company's core technology has been developed at Mayo Clinic and is under clinical evaluation. Its medical device therapies provide medical practitioners with a procedure that can be used to tailor brain stimulation therapy to each individual and enhance seizure control compared to currently used protocols. Cadence Neuroscience was established in 2017 and is headquartered in Redmond, Washington.

Funding History

October 2019$15.0M
February 2023$26.0M

Management

CEO

Kent Leyde

CSO

Doug Sheffield

Board Member

Gerry Brunk, MBA

Board Member

John F. Harris

Board Member

Kevin Chu

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo